CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Income Statement [Abstract]
Revenues	$ 71,667	$ 374,542
Cost of revenues	0	235,803
Gross profit	71,667	138,739
Operating expenses
General, administrative, research and development	2,008,118	4,570,161
Impairment of intangible assets	1,935,621	1,423,844
Warrants, options and stock	4,228,317	3,643,662
Fair value of common stock exchanged for warrants	3,069,792	0
Legal and professional services	1,071,392	2,128,898
Depreciation and amortization	675,757	164,043
Total operating expenses	12,988,997	11,930,608
Loss from operations	(12,917,330)	(11,791,869)
Other (income)/expenses
Fair value of derivative liabilities in excess of proceeds	0	408,501
(Gain)/loss on adjustments to fair value of derivative liability	(8,980,077)	(6,907,748)
Gain on extinguishment of derivative liability	(1,635,967)	0
Other (income)/expense	(71,631)	379,188
Present value of remaining lease payments for facilities no longer occupied	0	1,010,111
Interest expense	228,294	167,894
Total other income	(10,459,381)	(4,942,054)
Net loss	(2,457,949)	(6,849,815)
Net loss attributed to non-controlling interests	(6,401)	(19,079)
Net loss attributed to RestorGenex Corporation	(2,464,350)	(6,868,894)
Preferred dividends	$ 171,625	$ 497,167
Net loss attributable to RestorGenex Corporation common shareholders	$ (2,635,975)	$ (7,366,061)
Basic and diluted loss per share	$ (1.00)	$ (8.16)
Basic weighted average shares outstanding	2,646,603	903,139
Fully-diluted weighted average shares outstanding	2,646,603	1,121,987